DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: ketorolac tromethamine

Summary for Generic Name: ketorolac tromethamine

Tradenames:8
Patents:10
Applicants:24
NDAs:44
Drug Master File Entries: see list16
Suppliers: see list7
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for Ingredient: ketorolac tromethamine

Clinical Trials for: ketorolac tromethamine

Ketorolac in Postoperative Infants: Pharmacokinetics and Safety
Status: Completed Condition: Postoperative Pain in Infants

A Pilot Study Comparing the Analgesic Efficacy of IV Ibuprofen and IV Ketorolac
Status: Enrolling by invitation Condition: Chronic Pelvic Pain

Intranasal Ketorolac for Postsurgical Pain in Dental Implant Patients
Status: Completed Condition: Acute Pain

Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine
Status: Recruiting Condition: Migraines

Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy Subjects
Status: Completed Condition: Healthy Subjects

A Prospective Randomized Double-Blind Trial Comparing 3 Doses of Intravenous Ketorolac for Pain Management
Status: Recruiting Condition: Pain

The Use of Intranasal Ketoralac for Pain Management
Status: Recruiting Condition: Postoperative Pain Management; Urolithiasis

Study of Whether 15 mg Dose of Ketorolac IV is as Effective as a 30 mg Dose.
Status: Recruiting Condition: Pain; Pain, Postoperative

Disposition of Intravenous Ketorolac
Status: Completed Condition: Postoperative Pain

Pain Control for Intrauterine Device Placement: A Trial of Ketorolac Prior to Intrauterine Device Placement
Status: Completed Condition: Pain Control With IUD Insertion

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Agila Speclts
KETOROLAC TROMETHAMINE
ketorolac tromethamine
INJECTABLE;INJECTION078299Jul 16, 2007RXNo<disabled>
Agila Speclts
KETOROLAC TROMETHAMINE
ketorolac tromethamine
INJECTABLE;INJECTION201155Aug 4, 2014RXNo<disabled>
Amphastar Pharm
KETOROLAC TROMETHAMINE
ketorolac tromethamine
INJECTABLE;INJECTION076209Jul 21, 2004DISCNNo<disabled>
Apotex Inc
KETOROLAC TROMETHAMINE
ketorolac tromethamine
INJECTABLE;INJECTION075631Jun 29, 2001DISCNNo<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc